BIONET Therapeutics Corp. (TPEX: 7808)
Health Care · Biotechnology · TW
NT$37.00
-8.64% today · -36.2% 1Y
BIONET Therapeutics Corp. (TPEX: 7808) operates in the Biotechnology industry within the Health Care sector. The company is valued at $81.00M.
Over the last twelve months the share price has lost 36.2%, trading between 28.55 and 64.50.
Tweenvest scores BIONET Therapeutics Corp. across four factors: quality 54/100, value 56/100. Its strongest factor is value.
7808 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $81.00M
- Revenue (TTM)
- $6.18M
- P/E
- —
- EPS
- -1.20
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- NT$64.50
- 52-week low
- NT$28.55
- Avg volume (3M)
- —
- Shares outstanding
- 70.00M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Cardiff Oncology, Inc.NasdaqCM: CRDF | $84.02M | $1.01 | -6.48% |
| 3D Global Biotech Inc.TPEX: 6808 | $83.18M | NT$34.55 | +1.62% |
| Acrivon Therapeutics, Inc.NasdaqGM: ACRV | $81.85M | $1.75 | -8.38% |
| Prestige Biologics Co., Ltd.KOSDAQ: A334970 | $81.43M | ₩1,408.00 | -1.81% |
| Sera Prognostics, Inc.NasdaqGM: SERA | $80.48M | $2.06 | +0.74% |
| Greenland Mines LtdNasdaqCM: GRML | $80.35M | $5.50 | -8.72% |
| GlycoNex IncorporationTPEX: 4168 | $80.23M | NT$22.80 | +1.79% |
| BioPorto A/SCPSE: BIOPOR | $79.36M | Dkr1.04 | -2.80% |
Figures last refreshed Oct 11, 2026.